Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
mi
from
San Antonio, TX
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
mi
from
Everett, WA
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 10433
mi
from
Everett, WA
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
mi
from
Seattle, WA
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
mi
from
Helsinki,
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 200
mi
from
Helsinki,
Click here to add this to my saved trials
Parent-delivered Massage for Children With Autism
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated:  12/8/2015
mi
from
Corvallis, OR
Parent-delivered Massage for Children With Autism
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated: 12/8/2015
Various locations in Albany and Corvallis
mi
from
Corvallis, OR
Click here to add this to my saved trials
Parent-delivered Massage for Children With Autism
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated:  12/8/2015
mi
from
Eugene, OR
Parent-delivered Massage for Children With Autism
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated: 12/8/2015
Various locations in Eugene, Oregon
mi
from
Eugene, OR
Click here to add this to my saved trials
Parent-delivered Massage for Children With Autism
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated:  12/8/2015
mi
from
Portland, OR
Parent-delivered Massage for Children With Autism
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated: 12/8/2015
Various locations in Portland, Oregon
mi
from
Portland, OR
Click here to add this to my saved trials
Parent-delivered Massage for Children With Autism
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated:  12/8/2015
mi
from
Salem, OR
Parent-delivered Massage for Children With Autism
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated: 12/8/2015
Various locations in Salem, Oregon
mi
from
Salem, OR
Click here to add this to my saved trials
Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD
Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD
Status: Enrolling
Updated:  12/8/2015
mi
from
Fort Hood, TX
Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD
Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD
Status: Enrolling
Updated: 12/8/2015
Fort Hood Army Base
mi
from
Fort Hood, TX
Click here to add this to my saved trials
Parent-delivered Massage for Children With Autism - Ages 6 to 11
Phase 1 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism Ages 6 to 11
Status: Enrolling
Updated:  12/8/2015
mi
from
Portland, Salem, Albany, Corvallis, Eugene, OR
Parent-delivered Massage for Children With Autism - Ages 6 to 11
Phase 1 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism Ages 6 to 11
Status: Enrolling
Updated: 12/8/2015
Various locations in Portland, Salem, Albany/Corvallis and Eugene
mi
from
Portland, Salem, Albany, Corvallis, Eugene, OR
Click here to add this to my saved trials
Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic Stress Disorder
Evidence Based Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic Stress Disorder at the Saint Louis University Advanced Neurosurgical Innovation Center (SANIC)
Status: Enrolling
Updated:  12/9/2015
mi
from
St. Louis, MO
Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic Stress Disorder
Evidence Based Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic Stress Disorder at the Saint Louis University Advanced Neurosurgical Innovation Center (SANIC)
Status: Enrolling
Updated: 12/9/2015
Saint Louis University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Family Training Program for Parents of Substance Using Adolescents
CRAFT: Helping Parents Initiate and Support Their Adolescent's Treatment
Status: Enrolling
Updated:  12/9/2015
mi
from
Philadelphia, PA
Family Training Program for Parents of Substance Using Adolescents
CRAFT: Helping Parents Initiate and Support Their Adolescent's Treatment
Status: Enrolling
Updated: 12/9/2015
Family Training Program
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)
A Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Repeat Oral Doses of V81444 in Volunteers With Attention Deficit / Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/9/2015
mi
from
Kansas City, KA
Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)
A Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Repeat Oral Doses of V81444 in Volunteers With Attention Deficit / Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/9/2015
Vince and Associates Clinical Research
mi
from
Kansas City, KA
Click here to add this to my saved trials
Behavioral Treatment for Children With Conduct Problems and Callous-Unemotional Traits
Designing a Novel Behavioral Treatment Protocol for Children Characterized by Conduct Problems and Callous-unemotional Traits
Status: Enrolling
Updated:  12/10/2015
mi
from
Miami, FL
Behavioral Treatment for Children With Conduct Problems and Callous-Unemotional Traits
Designing a Novel Behavioral Treatment Protocol for Children Characterized by Conduct Problems and Callous-unemotional Traits
Status: Enrolling
Updated: 12/10/2015
Florida International University
mi
from
Miami, FL
Click here to add this to my saved trials
Changes in Quadriceps Function Following Local or Distant Interventions in Individuals With Patellofemoral Pain
Changes in Quadriceps Function Following Local or Distant Interventions in Individuals With Patellofemoral Pain
Status: Enrolling
Updated:  12/10/2015
mi
from
Omaha, NE
Changes in Quadriceps Function Following Local or Distant Interventions in Individuals With Patellofemoral Pain
Changes in Quadriceps Function Following Local or Distant Interventions in Individuals With Patellofemoral Pain
Status: Enrolling
Updated: 12/10/2015
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Vilazodone Treatment for Marijuana Dependence
Vilazodone Treatment for Marijuana Dependence
Status: Enrolling
Updated:  12/10/2015
mi
from
Charleston, SC
Vilazodone Treatment for Marijuana Dependence
Vilazodone Treatment for Marijuana Dependence
Status: Enrolling
Updated: 12/10/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Effect of Oxytocin on Craving and Therapy Response
Effect of Oxytocin on Craving and Therapy Response in Marijuana-dependent Individuals
Status: Enrolling
Updated:  12/10/2015
mi
from
Charleston, SC
Effect of Oxytocin on Craving and Therapy Response
Effect of Oxytocin on Craving and Therapy Response in Marijuana-dependent Individuals
Status: Enrolling
Updated: 12/10/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
Status: Enrolling
Updated:  12/10/2015
mi
from
Providence, RI
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
Status: Enrolling
Updated: 12/10/2015
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
e-Cigarettes Versus NRT Gum for Smoking Cessation
e-Cigarettes Versus Nicotine Replacement Therapy for Smoking Cessation
Status: Enrolling
Updated:  12/10/2015
mi
from
Omaha, NE
e-Cigarettes Versus NRT Gum for Smoking Cessation
e-Cigarettes Versus Nicotine Replacement Therapy for Smoking Cessation
Status: Enrolling
Updated: 12/10/2015
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Effects of CPAP Therapy on PTSD Symptoms
Effects of Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea on PTSD Symptoms
Status: Enrolling
Updated:  12/10/2015
mi
from
San Diego, CA
Effects of CPAP Therapy on PTSD Symptoms
Effects of Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea on PTSD Symptoms
Status: Enrolling
Updated: 12/10/2015
VA San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Behavior Therapy for Children With Chronic Tic Disorders
Status: Enrolling
Updated:  12/10/2015
mi
from
Los Angeles, CA
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Behavior Therapy for Children With Chronic Tic Disorders
Status: Enrolling
Updated: 12/10/2015
UCLA Child OCD, Anxiety, and Tic Disorders Program
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Behavior Therapy for Children With Chronic Tic Disorders
Status: Enrolling
Updated:  12/10/2015
mi
from
Baltimore, MD
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Behavior Therapy for Children With Chronic Tic Disorders
Status: Enrolling
Updated: 12/10/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Behavior Therapy for Children With Chronic Tic Disorders
Status: Enrolling
Updated:  12/10/2015
mi
from
Milwaukee, WI
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Behavior Therapy for Children With Chronic Tic Disorders
Status: Enrolling
Updated: 12/10/2015
University of Wisconsin-Milwaukee
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Effect of Oxytocin on Stress in Marijuana Users
Effect of Oxytocin on Stress Response in Marijuana-dependent Individuals
Status: Enrolling
Updated:  12/10/2015
mi
from
Charleston, SC
Effect of Oxytocin on Stress in Marijuana Users
Effect of Oxytocin on Stress Response in Marijuana-dependent Individuals
Status: Enrolling
Updated: 12/10/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
Status: Enrolling
Updated:  12/11/2015
mi
from
West Haven, CT
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
Status: Enrolling
Updated: 12/11/2015
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
mi
from
Bufflo, NY
SUNY at Buffalo
mi
from
Bufflo, NY
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Cerritos, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Comprehensive Clinical Development Inc.
mi
from
Cerritos, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Encino, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Pharmacology Research Institute
mi
from
Encino, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Imperial, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Sun Valley Research Center
mi
from
Imperial, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Oceanside, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Orange, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
NRC Research Institute
mi
from
Orange, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
San Diego, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
San Diego, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
California Neuorpsychopharmacology Clinical Research Institute, LLC (CNRI-San Diego, LLC)
mi
from
San Diego, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Hartford, CT
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
DeLand, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Fort Meyers, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Gulfcoast Clinical Center
mi
from
Fort Meyers, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Gainesville, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Sarkis Clinical Trials
mi
from
Gainesville, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Hialeah, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Berma Research Group
mi
from
Hialeah, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Lake City, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Sarkis Clinical Trials
mi
from
Lake City, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Orlando, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Tampa, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Stedman Clinical Trials
mi
from
Tampa, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Alpharetta, GA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Atlanta, GA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Roswell, GA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Northwest Behavioral Research Center
mi
from
Roswell, GA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Chicago, IL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Great Lakes Clinical Trials
mi
from
Chicago, IL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Prairie Village, KA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Phoenix Medica Research, Inc
mi
from
Prairie Village, KA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Baltimore, MD
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Pharmasite Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Methuen, MA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
ActivMed Practices & Research
mi
from
Methuen, MA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Natick, MA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
BCCR Trials
mi
from
Natick, MA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
mi
from
Lincoln, NE
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Premier Psychiatric Research Institute, LLC
mi
from
Lincoln, NE
Click here to add this to my saved trials